These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21254696)

  • 21. Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure.
    Manzano-Fernández S; Januzzi JL; Boronat-García M; Pastor P; Albaladejo-Otón MD; Garrido IP; Bayes-Genis A; Valdés M; Pascual-Figal DA
    Congest Heart Fail; 2010; 16(5):214-20. PubMed ID: 20887618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.
    Rogers RK; May HT; Anderson JL; Muhlestein JB
    Am Heart J; 2009 Nov; 158(5):777-83. PubMed ID: 19853697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes.
    Yamamoto T; Sato N; Yasutake M; Takagi H; Morita N; Akutsu K; Fujii M; Fujita N; Tanaka K; Takano T
    Int J Cardiol; 2006 Aug; 111(2):224-30. PubMed ID: 16185779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
    Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
    Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
    Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study.
    Dieplinger B; Mueller T; Kollerits B; Struck J; Ritz E; von Eckardstein A; Haltmayer M; Kronenberg F;
    Kidney Int; 2009 Feb; 75(4):408-14. PubMed ID: 19052536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
    Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in plasma B-type natriuretic peptide after allograft renal transplantation.
    Wei TM; Jin L; Lv LC; Zhang BJ; Wang LX
    Nephrology (Carlton); 2007 Feb; 12(1):102-6. PubMed ID: 17295669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino-terminal pro-B-type natriuretic peptide testing in renal disease.
    DeFilippi C; van Kimmenade RR; Pinto YM
    Am J Cardiol; 2008 Feb; 101(3A):82-8. PubMed ID: 18243865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation.
    Klaar U; Gabriel H; Bergler-Klein J; Pernicka E; Heger M; Mascherbauer J; Rosenhek R; Binder T; Maurer G; Baumgartner H
    Eur J Heart Fail; 2011 Feb; 13(2):163-9. PubMed ID: 21051463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation.
    Hussein AA; Saliba WI; Martin DO; Shadman M; Kanj M; Bhargava M; Dresing T; Chung M; Callahan T; Baranowski B; Tchou P; Lindsay BD; Natale A; Wazni OM
    Circulation; 2011 May; 123(19):2077-82. PubMed ID: 21536999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
    Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
    Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease.
    Austin WJ; Bhalla V; Hernandez-Arce I; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
    Am J Clin Pathol; 2006 Oct; 126(4):506-12. PubMed ID: 16938661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.